14th Jul 2025 12:17
(Alliance News) - Physiomics PLC on Monday predicted annual results "ahead of expectations", and noted that contract wins have reached "a record high" total value.
The Oxfordshire, England-based mathematical modelling company anticipates reporting around GBP834,000 in total income and a GBP419,000 post-tax loss, "both metrics being ahead of expectations" for the year ended June 30.
In its financial 2024 earnings report, released in September, Physiomics reported GBP570,561 in total income and a post-tax loss of GBP670,816.
The expected financial 2025 figures would therefore represent a narrowed loss and an approximate 46% rise in total income, "reflecting the positive growth trajectory of the business and effective cost management", Physiomics said.
Also, over financial 2024 and 2025, Physiomics' average total value of contract wins "[reached] a record high of over [GBP1 million] per year, a 63% increase on the yearly average over the previous five years".
Physiomics further reported, as of the start of the year ending June 30, 2026, around GBP593,000 of contracted revenue projected to be recognised within that period. It said this represents a 19% increase from the about GBP500,000 worth of contracts carried from financial 2023 into financial 2024.
"We are therefore confident that further revenue growth can be achieved in FY26," Physiomics stated.
Most recently, on Tuesday last week, Physiomics announced the signing of a new 18-month contract worth GBP98,600 with an existing client to apply PK/PD modelling and simulation expertise "to support preclinical-to-clinical translation for one of the client's lead candidates".
The company also said it expects grant income worth GBP60,000 to be recognised in the current year.
Chief Executive Officer Peter Sargent commented: "I am thrilled that the changes we've made here at Physiomics are starting to have a positive effect on the company's performance.
"Not only will we exceed expectations for FY25, but we've started FY26 with record levels of contracted revenue yet to be recognised and are generating significant momentum across our key growth initiatives."
Shares in Physiomics were 2.7% higher at 0.49 pence in London on Monday. However, the stock has lost 28% over the past year.
By Emma Curzon, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Physiomics